CPAI - ETF AI Analysis
Top Page
Counterpoint Quantitative Equity ETF (CPAI)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, suggesting its strategy has recently worked well for investors.
Leading Holdings with Strong Momentum
Several of the largest positions, including names in energy, health care, and technology, have shown strong performance, helping drive the fund’s returns.
Sector Diversification Across Key Industries
Holdings spread across technology, health care, energy, and several other sectors help reduce the impact if any single industry runs into trouble.
Negative Factors
High Expense Ratio
The fund’s relatively high fee means more of the gross return is eaten up by costs compared with many other ETFs.
Heavy U.S. Concentration
With almost all assets in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.
Short-Term Performance Bumpiness
The recent slight decline over the past month shows that returns can be choppy in the short term, even when longer-term performance looks strong.
CPAI vs. SPDR S&P 500 ETF (SPY)
AUM401.30M
RegionNorth America
Expense Ratio0.75%
Beta1.08
IssuerCounterpoint
Inception DateNov 28, 2023
Dividend Yield0.71%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume80,456
30 Day Avg. Volume63,606
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
61.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CPAI Summary
The Counterpoint Quantitative Equity ETF (CPAI) is a U.S. stock fund that uses a data-driven strategy instead of tracking a set index. It aims to cover the total U.S. market, mixing different sizes and styles of companies, from growth to value. Its holdings span many sectors, with a big focus on technology and health care, and include well-known names like Apple and ConocoPhillips. Someone might invest in CPAI to get broad diversification and long-term growth in a single fund. A key risk is that it is heavily invested in U.S. stocks, so its value can rise and fall sharply with the overall stock market.
How much will it cost me?The Counterpoint Quantitative Equity ETF (CPAI) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is actively managed, using a quantitative approach to select stocks rather than simply tracking an index.
What would affect this ETF?The Counterpoint Quantitative Equity ETF (CPAI), with its focus on the U.S. market and diverse sector exposure, could benefit from strong growth in technology and healthcare sectors, driven by innovation and increased demand. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact consumer spending and cyclical industries. Regulatory changes or geopolitical tensions affecting North America could also influence the ETF's performance.
CPAI Top 10 Holdings
CPAI leans heavily into U.S. tech and health care, with Apple and HP providing a steady tech backbone as their shares keep grinding higher rather than sprinting. In health care, 10x Genomics has been a rising star, giving the fund a shot of growth, while Fastly’s more mixed, stop‑and‑go performance keeps returns from running too far ahead. On the energy side, Cenovus and Occidental are quietly pulling their weight, though BellRing Brands in consumer staples is losing steam and slightly dragging on results. Overall, it’s a U.S.-centric, sector-diversified mix with a tilt toward innovative growth names.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| PBF Energy | 2.87% | $11.49M | $8.57B | 180.24% | 55 Neutral | |
| Fastly | 2.68% | $10.74M | $3.55B | 228.47% | 63 Neutral | |
| NetApp | 2.54% | $10.19M | $35.03B | 78.44% | 76 Outperform | |
| 10x Genomics | 2.51% | $10.07M | $6.00B | 323.35% | 60 Neutral | |
| HP | 2.50% | $10.01M | $24.94B | 15.09% | 61 Neutral | |
| Hewlett Packard Enterprise | 2.42% | $9.72M | $63.43B | 155.74% | 68 Neutral | |
| Cboe Global Markets | 2.42% | $9.70M | $32.47B | 13.46% | 75 Outperform | |
| McKesson | 2.31% | $9.25M | $100.24B | 30.06% | 62 Neutral | |
| Verra Mobility | 2.30% | $9.23M | $803.59M | -79.14% | 63 Neutral | |
| Cencora | 2.30% | $9.22M | $60.57B | 12.39% | 70 Neutral |
CPAI Technical Analysis
Positive
―
Price Trends
50.73
Positive
48.00
Positive
44.72
Positive
Market Momentum
0.07
Negative
53.16
Neutral
57.35
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CPAI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 50.55, equal to the 50-day MA of 50.73, and equal to the 200-day MA of 44.72, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 53.16 is Neutral, neither overbought nor oversold. The STOCH value of 57.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CPAI.
CPAI Peer Comparison
Comparison Results
Performance Comparison
CPAI
Counterpoint Quantitative Equity ETF
51.07
15.34
42.93%
VFMF
Vanguard U.S. Multifactor ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
AVTM
Avantis Total Equity Markets ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
XCHG
AB US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents